GESTIÓN EN SALUD PÚBLICA: An In-Depth Look at the Final FDA Guidance: Bioavailability Studies Submitted in NDAs or INDs – General Considerations - 10/26/2022 | FDA

miércoles, 19 de octubre de 2022

An In-Depth Look at the Final FDA Guidance: Bioavailability Studies Submitted in NDAs or INDs – General Considerations - 10/26/2022 | FDA

An In-Depth Look at the Final FDA Guidance: Bioavailability Studies Submitted in NDAs or INDs – General Considerations - 10/26/2022 | FDA

No hay comentarios:

Publicar un comentario

Suscribirse a: Enviar comentarios (Atom)